Thursday February 9, 2012
Share ...
  • email
  • Google Bookmarks
  • Facebook
  • Twitter
  • Digg
  • LinkedIn
  • RSS
Print Print
Boardroom News
TPG to buy GlobeOp for $801.5 million
February 2, 2012

TPG Capital will purchase GlobeOp Financial Services for $801.5 million, paying 22.5 percent more than GlobeOp's Jan. 31 closing price.

Xstrata confirms Glencore merger approach
February 2, 2012

Xstrata has confirmed it is in merger discussions with Glencore International, though the company is cautioning that no deal is imminent.

Facebook sets stage for historic IPO
February 2, 2012

Facebook announced its $5 billion IPO yesterday, valuing the social network at up to $100 billion.

Sony’s new chief reveals his plans
February 2, 2012

The new chief executive of Sony promises to forge a new path for a company that once dominated the business of filling free time with the creation of wildly popular consumer products.

Merck swings to profit
February 2, 2012

Drug maker Merck swung to a profit amid fewer acquisition-related and restructuring charges, and it also reported a modest increase in revenue.

Deutsche Bank profit dented by crisis
February 2, 2012

Germany's Deutsche Bank painted a bleak picture for 2012, after fallout from Europe's financial crisis dented fourth-quarter net profit with write-downs and sharply lower investment bank activity.

Lauzon: My experience as a private-equity CEO
February 1, 2012

Managers like me are required to put our own capital into the company.

News & Trends in Management
February 1, 2012

Move over M.B.A.s, engineers are far more prevalent in companies' top ranks, a new study says. Plus, CEOs are making transparency a priority.

Adviser Is Another Facebook Winner
February 1, 2012

Facebook executives stand to collect massive windfalls in the social-networking site's upcoming IPO. Another big winner: their wealth manager.

SEC Charges Former Credit Suisse Investment Bankers in Subprime Bond Pricing Scheme During Credit Crisis
February 1, 2012

FOR IMMEDIATE RELEASE
2012-23

Washington, D.C., Feb 1, 2012 – The Securities and Exchange Commission today charged four former veteran investment bankers and traders at Credit Suisse Group for engaging in a complex scheme to fraudulently overstate t...

Avon fires vice chairman
February 1, 2012

Avon Vice Chairman Charles Cramb has been fired amidst an investigation into allegations that company officials bribed foreign officials and made improper disclosures.

Political spending proxy measures: One size doesn’t fit all
February 1, 2012

ISS has opted for a "case-by-case" approach on political spending disclosure voting recommendations.

Corporate directors did not violate Wisconsin law in merger deal
February 1, 2012

A shareholder accusing Ladish directors of breaking the law by failing to disclose material facts to investors before selling the corporation will not receive damages.

Bill to prohibit insider trading by members of Congress advances in Senate
February 1, 2012

The U.S. Senate has voted to back a bill excluding members of Congress from trading stocks and other securities using confidential information they receive as lawmakers.

Yazaki, Denso to plead guilty to price-fixing
February 1, 2012

Japan's Yazaki Corp. has been charged the second-highest fine, $470 million, imposed on a company for price-fixing in history.

Kodak employee sues directors over stock
February 1, 2012

Eastman Kodak employee Mark Gedek has filed a civil suit against the company's board and fiduciaries of the retirement plans accusing them of breaching duties as the company neared bankruptcy.

U.S. widens case versus ex-Goldman Director Rajat Gupta
February 1, 2012

Rajat Gupta's insider-trading case has expanded with a new criminal indictment increasing the number of illegal tips he is charged with.

Deutsche Boerse-NYSE Euronext merger blocked by EU regulators
February 1, 2012

The European Commission has blocked the Deutsche Borse/NYSE Euronext merger on the grounds that a united entity would impede effective competition.

10 Best ‘Dividend Aristocrats’ for 2012
February 1, 2012

Data suggest that these 10 dividend stocks may outperform in 2012 and beyond.
Click to view a price quote on BFB.
Click to research the Food & Beverage industry.

Takeda Pharmaceutical Profit Falls 26%
February 1, 2012

Takeda, Japan's biggest drug maker, cut its earnings outlook on streamlining costs after last year's $13.7 billion acquisition of Swiss drug maker Nycomed, while rival Astellas appears headed toward a new growth phase.